• What we do
    • Purpose
    • Hallmarks of aging
    • Portfolio
    • How we work
  • Who we are Who we are Join us
    • Join Us
    • People
  • News
  • Contact
info@rejuveron.com linkedin open positions
Second Rejuveron company transitions into clinical stage as first patient is dosed in trial of Endogena Therapeutics’ novel regenerative treatment for blindness caused by retinitis pigmentosa
Rejuveron has moved to its new incubator space in the Bio-Technopark in Schlieren-Zürich

Rejuveron will das Altern bremsen

We use cookies to analyse traffic and improve our services. Read more about our privacy policy here
Rejuveron Life Sciences AG
  • Privacy policy

Wagistrasse 18
CH-8952 Schlieren - Zürich
Switzerland
+41 44 730 12 90

info@rejuveron.com

investor relations
Partnering

LinkedIn

Youtube

Instagram

Twitter

  • Privacy policy